Be the match biotherapies® and cryoport partner to accelerate the development of cell and gene therapies

Partnership will provide access to standardized and optimized apheresis collection, cryopreservation and bioprocessing processes throughout the u.s. and europe minneapolis and nashville, tenn. , oct. 9, 2023 /prnewswire/ -- be the match biotherapies® , an organization offering solutions for companies developing and commercializing cell and gene therapies, and cryoport (nasdaq: cyrx), a leading global provider of innovative products and services to the fast-growing cell & gene therapy industry enabling the future of medicine for a new era of life sciences, today announced a new strategic partnership.
CYRX Ratings Summary
CYRX Quant Ranking